Correspondence 0001493152-25-009317 from Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc.
Date: March 6, 2025 · CIK: 0001757499 · Accession: 0001493152-25-009317
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284889
Letter
SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
Professional Drive, Suite 260
Gaithersburg, MD 20879
(240) 430-4212
March 6, 2025
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Re: Shuttle Pharmaceuticals Holdings, Inc.
Registration Statement on Form S-1
File No. 333-284889
Acceleration Request
Requested Date: Friday, March 7, 2025
Requested Time: 4:30 PM Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Shuttle Pharmaceuticals Holdings, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its registration statement on Form S-1 (File No. 333-284889) so that it may become effective at 4:30 p.m. Eastern Time on Friday, March 7, 2025, or at such time as the Registrant may request by telephone to the staff of the Securities and Exchange Commission. In addition, the Registrant hereby authorizes Megan J. Penick, Esq. of Dorsey & Whitney LLP, counsel for the Registrant, to make such request on the Registrant’s behalf.
Very
truly yours,
Shuttle
Pharmaceuticals Holdings, Inc.
Show Raw Text
CORRESP
1
filename1.htm
SHUTTLE
PHARMACEUTICALS HOLDINGS, INC.
401
Professional Drive, Suite 260
Gaithersburg,
MD 20879
(240)
430-4212
March
6, 2025
Via
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Shuttle
Pharmaceuticals Holdings, Inc.
Registration
Statement on Form S-1
File
No. 333-284889
Acceleration
Request
Requested
Date:
Friday,
March 7, 2025
Requested
Time:
4:30
PM Eastern Time
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, Shuttle Pharmaceuticals Holdings, Inc. (the “Registrant”)
hereby requests acceleration of the effective date of its registration statement on Form S-1 (File No. 333-284889) so that it may become
effective at 4:30 p.m. Eastern Time on Friday, March 7, 2025, or at such time as the Registrant may request by telephone to the staff
of the Securities and Exchange Commission. In addition, the Registrant hereby authorizes Megan J. Penick, Esq. of Dorsey & Whitney
LLP, counsel for the Registrant, to make such request on the Registrant’s behalf.
Very
truly yours,
Shuttle
Pharmaceuticals Holdings, Inc.
By:
/s/
Anatoly Dritschilo
Name:
Anatoly
Dritschilo
Title:
Chief
Executive Officer and
Chairman
of the Board of Directors